Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review

Malaria Journal

Volumn 15, Issue 1, 2016, Pages 1-21

  Adhikari, Bipin ^a   James, Nicola ^a   Newby, Gretchen ^b   Von Seidlein, Lorenz ^a,d   White, Nicholas J ^a,d   Day, Nicholas P J ^a,d   Dondorp, Arjen M ^a,d   Pell, Christopher ^e   Cheah, Phaik Yeong ^a,c,d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Community; Engagement; Malaria; MDA; Population coverage

Indexed keywords

ANTIMALARIAL AGENT;

COMMUNITY CARE; COMMUNITY ENGAGEMENT; COMMUNITY STRUCTURE; DIRECTLY OBSERVED THERAPY; GOVERNMENT; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HUMAN RESOURCE MOBILIZATION; POPULATION COVERAGE; POPULATION RESEARCH; POPULATION SIZE; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; REVIEW; SOCIAL ENVIRONMENT; SYSTEMATIC REVIEW; THEMATIC ANALYSIS; COMMUNITY PARTICIPATION; DISEASE ERADICATION; DISEASE TRANSMISSION; DRUG UTILIZATION; MALARIA; PREVENTION AND CONTROL; PROCEDURES; SOUTHEAST ASIA; TRANSMISSION;

ANTIMALARIALS; ASIA, SOUTHEASTERN; COMMUNITY PARTICIPATION; DISEASE ERADICATION; DISEASE TRANSMISSION, INFECTIOUS; DRUG UTILIZATION; HUMANS; MALARIA;

EID: 84994745079     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1593-y     Document Type: Review

References (85)

1. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23.
2. Mbengue A, Bhattacharjee S, Pandharkar T, Liu H, Estiu G, Stahelin RV, et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature. 2015;520:683-7.
3. WHO. About the emergency response to artemisinin resistance in the Greater Mekong subregion. Geneva: World Health Organization; 2014. http://www.who.int/malaria/areas/greater_mekong/overview/en/. Accessed 4 Sept 2016.
4. WHO. Activities for the monitoring and containment of artemisinin resistance. Geneva: World Health Organization; 2015. http://www.who.int/malaria/areas/greater_mekong/activities/en/. Accessed 4 Sept 2016.
5. von Seidlein L, Dondorp A. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther. 2015;13:715-30.
6. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93:125-34.
7. von Seidlein L, Greenwood BM. Mass administrations of antimalarial drugs. Trends Parasitol. 2003;19:452-60.
8. Hsiang MS, Hwang J, Tao AR, Liu Y, Bennett A, Shanks GD, et al. Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province. China. Malar J. 2013;12:383.
9. De Martin S, von Seidlein L, Deen JL, Pinder M, Walraven G, Greenwood B. Community perceptions of a mass administration of an antimalarial drug combination in The Gambia. Trop Med Int Health. 2001;6:442-8.
10. Dial NJ, Ceesay SJ, Gosling RD, D'Alessandro U, Baltzell KA. A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia. Malar J. 2014;13:47.
11. Maude RJ, Socheat D, Nguon C, Saroth P, Dara P, Li G, et al. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance. PLoS ONE. 2012;7:e37166.
12. Shekalaghe SA, Drakeley C, van den Bosch S, ter Braak R, van den Bijllaardt W, Mwanziva C, et al. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar J. 2011;10:247.
13. White NJ. The role of anti-malarial drugs in eliminating malaria. Malar J. 2008;7(Suppl 1):S8.
14. Kaneko A. A community-directed strategy for sustainable malaria elimination on islands: short-term MDA integrated with ITNs and robust surveillance. Acta Trop. 2010;114:177-83.
15. Bhullar N, Maikere J. Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia. Parasit Vectors. 2010;3:70.
16. Cantey PT, Rout J, Rao G, Williamson J, Fox LM. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLoS Negl Trop Dis. 2010;4:e728.
17. Cheah PY, White NJ. Antimalarial mass drug administration: ethical considerations. Int Health. 2016;8:235-8.
18. Tindana PO, Singh JA, Tracy CS, Upshur RE, Daar AS, Singer PA, et al. Grand challenges in global health: community engagement in research in developing countries. PLoS Med. 2007;4:e273.
19. CTSA. Clinical and translational science awards consortium. Principles of community engagement. 2nd ed. NIH Publication No 11-7782. 2011.
20. Atkinson JA, Vallely A, Fitzgerald L, Whittaker M, Tanner M. The architecture and effect of participation: a systematic review of community participation for communicable disease control and elimination. Implications for malaria elimination. Malar J. 2011;10:225.
21. WHO special programme for research and training in tropical diseases. Community-directed interventions for major health problems in Africa: a multi-country study: final report. Geneva: World Health Organization; 2008.
22. CDI Study Group. Community-directed interventions for priority health problems in Africa: results of a multicountry study. Bull World Health Organ. 2010;88:509-18.
23. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;12:CD008846.
24. Dola SK. Mass drug administration as a supplementary attack measure in malaria eradication programme. East Afr Med J. 1974;51:529-31.
25. Lwin KM, Imwong M, Suangkanarat P, Jeeyapant A, Vihokhern B, Wongsaen K, et al. Elimination of Plasmodium falciparum in an area of multi-drug resistance. Malar J. 2015;14:319.
26. Berberian DA, Dennis EW. Field experiments with chloroquine diphosphate. Am J Trop Med Hyg. 1948;28:755-76.
27. Garfield RM, Vermund SH. Changes in malaria incidence after mass drug administration in Nicaragua. Lancet. 1983;2:500-3.
28. Gribben G. Mass treatment with plasmoquine. BMJ. 1933;3802:919-20.
29. Handerson LH. Prophylaxis of malaria in the Sudan, with special reference to the use of plasmoquine. Trans R Soc Trop Med Hyg. 1934;28:157-64.
30. Garfield RM, Vermund SH. Health education and community participation in mass drug administration for malaria in Nicaragua. Soc Sci Med. 1986;22:869-77.
31. Pribadi W, Muzaham F, Santoso T, Rasidi R, Rukmono B. The implementation of community participation in the control of malaria in rural Tanjung Pinang, Indonesia. Southeast Asian J Trop Med Public Health. 1986;17:371-8.
32. Clyde DF. Malaria control in Tanganyika under the German administration. I. E. East Afr Med J. 1961;38:27-42.
33. Charles LJ, Van Der Kaay HJ, Vincke IH, Brady J. The appearance of pyrimethamine resistance in Plasmodium falciparum following self-medication by a rural community in Ghana. Bull World Health Organ. 1962;26:103-8.
34. Baukapur SN, Babu CJ. A focal outbreak of malaria in Valsad district, Gujarat state. J Commun Dis. 1984;16:268-72.
35. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A. Malaria eradication on islands. Lancet. 2000;356:1560-4.
36. Butler FA. Malaria control program on a South Pacific base. US Nav Med Bull. 1943;41:1603-12.
37. Sehgal JK. Progress of malaria eradication in Orissa State during 1965-1966. Bull Ind Soc Mal Com Dis. 1968;5:88-93.
38. Dapeng L, Leyuan S, Xili L, Xiance Y. A successful control programme for falciparum malaria in Xinyang, China. Trans R Soc Trop Med Hyg. 1996;90:100-2.
39. Gabaldon A, Guerrero L. An attempt to eradicate malaria by the weekly administration of pyrimethamine in areas of out-of-doors transmission in Venezuela. Am J Trop Med Hyg. 1959;8:433-9.
40. Roberts JM. The control of epidemic malaria in the highlands of Western Kenya. I. Before the campaign. J Trop Med Hyg. 1964;67:161-8.
41. Cheah PY, Lwin KM, Phaiphun L, Maelankiri L, Parker M, Day NP, et al. Community engagement on the Thai-Burmese border: rationale, experience and lessons learnt. Int Health. 2010;2:123-9.
42. von Seidlein L, Walraven G, Milligan PJ, Alexander N, Manneh F, Deen JL, et al. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg. 2003;97:217-25.
43. Song J, Socheat D, Tan B, Dara P, Deng C, Sokunthea S, et al. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine. Malar J. 2010;9:57.
44. Doi H, Kaneko A, Panjaitan W, Ishii A. Chemotherapeutic malaria control operation by single dose of fandisar plus primaquine in North Sumatra, Indonesia. Southeast Asian J Trop Med Public Health. 1989;20:341-9.
45. Archibald HM. Field trials of mass administration of antimalarial drugs in northern Nigeria. World Health Organization; 1960. WHO/MAL/262-11.
46. Clyde DF. Mass administration of an antimalarial drug combining 4-aminoquinoline and 8-aminoquinoline in Tanganyika. Bull World Health Organ. 1962;27:203-12.
47. MacCormack CP, Lwihula G. Failure to participate in a malaria chemo suppression programme: North Mara, Tanzania. J Trop Med Hyg. 1983;86:99-107.
48. Kaseje DC, Sempebwa EK. An integrated rural health project in Saradidi, Kenya. Soc Sci Med. 1989;28:1063-71.
49. Head BW. Community Engagement: participation on Whose Terms? Aust J Political Sci. 2007;42:441-54.
50. Rifkin SB. Paradigms lost: toward a new understanding of community participation in health programmes. Acta Trop. 1996;61:79-92.
51. Greenough P. Intimidation, coercion and resistance in the final stages of the South Asian smallpox eradication campaign, 1973-1975. Soc Sci Med. 1995;41:633-45.
52. Rieckmann KH. The chequered history of malaria control: are new and better tools the ultimate answer? Ann Trop Med Parasitol. 2006;100:647-62.
53. Purdey AF, Adhikari GB, Robinson SA, Cox PW. Participatory health development in rural Nepal: clarifying the process of community empowerment. Health Educ Q. 1994;21:329-43.
54. Aregawi M, Smith SJ, Sillah-Kanu M, Seppeh J, Kamara AR, Williams RO, et al. Impact of the mass drug administration for malaria in response to the Ebola outbreak in Sierra Leone. Malar J. 2016;15:480.
55. Kuehne A, Tiffany A, Lasry E, Janssens M, Besse C, Okonta C, et al. Impact and lessons learned from mass drug administrations of malaria chemoprevention during the Ebola Outbreak in Monrovia, Liberia, 2014. PLoS ONE. 2016;11:e0161311.
56. Adhikari B, Mishra SR, Raut S. Rebuilding earthquake struck Nepal through community engagement. Front Public Health. 2016;4:121.
57. Lavery JV. Putting international research ethics guidelines to work for the benefit of developing countries. Yale J Health Policy Law Ethics. 2004;4:319-36.
58. Kingsbury AN, Amies CR. A field experiment on the value of plasmoquine in the prophylaxis of malaria. Trans R Soc Trop Med Hyg. 1931;25:159-72.
59. Kligler IJ, Mer G. Periodic intermittent treatment with chinoplasmine as a measure of malaria control in a hyperendemic area. Riv Malariol. 1931;10:425-38.
60. White RS, Adhikari AK. Anti-gametocyte treatment combined with anti-larval malaria control. Rec Malar Surv Ind. 1934;4:77-94.
61. Ray AP. Prophylactic use of paludrine in a tea estate. Indian J Malariol. 1948;2:35-66.
62. Banerjea R. The control of malaria in a rural area of West Bengal. Indian J Malariol. 1949;3:371-86.
63. Van Goor WT, Lodens JG. Clinical malaria prophylaxis with proguanil. Doc Neerl Indones Morbis Trop. 1950;2:62-81.
64. Norman T. An investigation of the failure of proguanil prophylaxis. Trans R Soc Trop Med Hyg. 1952;46:653-5.
65. Archibald HM, Bruce-Chwatt LJ. Suppression of malaria with pyrimethamine in Nigerian school children. Bull World Health Organ. 1956;15:775-84.
66. Clyde DF, Webbe G, Shute GT. Single dose pyrimethamine treatment of Africans during a malaria epidemic in Tanganyika. East Afr Med J. 1958;35:23-9.
67. Van Dijk W. Mass chemoprophylaxis with chloroquine additional to DDT indoor spraying. Trop Geogr Med. 1958;10:379-84.
68. Afridi MK, Rahim A. Further observation on the interruption of malaria transmission with single dose of pyrimethamine (daraprim). Riv Parassitol. 1959;20:229-42.
69. Van Dijk W. Mass treatment of malaria with chloroquine: results of a trial in Inanwatan. Trop Geogr Med. 1961;13:351-6.
70. Metselaar D. Seven years' malaria research and residual house spraying in Netherlands New Guinea. Am J Trop Med Hyg. 1961;10:327-34.
71. Ho C. Studies on malaria in new China. Chin Med J. 1965;84:491-7.
72. Ossi GT. An epidemic in the life of a malaria eradication programme. Bull Endem Dis. 1967;9:5-18.
73. Singh MV, Agarwala RS, Singh KN. Epidemiological study of focal outbreak of malaria in consolidation phase area and evaluation of remedial measures in Uttar Pradesh (India). Bull Ind Soc Mal Com Dis. 1968;5:207-20.
74. Lakshmanacharyulu T, Guha AK, Kache SR. Control of malaria epidemics in a river valley project. Bull Ind Soc for Mal Com. 1968;5:94-105.
75. Onori E. Experience with mass drug administration as a supplementary attack measure in areas of vivax malaria. Bull World Health Organ. 1972;47:543-8.
76. Najera JA, Shidrawi GR, Storey J, Lietaert PEA. Mass drug administration and DDT indoor-spraying as antimalarial measures in the northern savanna of Nigeria. Malar Bull World Health Organ. 1973;73:1-34.
77. Schliessmann DJ, Joseph VR, Solis M, Carmichael GT. Drainage and larviciding for control of a malaria focus in Haiti. Mosq News. 1973;33:371-8.
78. Paik HY. Problem areas in the malaria eradication programme in the British Solomon Islands. PNG Med J. 1974;17:111-5.
79. Kondrashin AV, Sanyal MC. Mass drug administration in Andhra Pradesh in areas under Plasmodium falciparum containment programme. J Commun Dis. 1985;17:293-9.
80. Strickland GT, Khaliq AA, Sarwar M, Hassan H, Pervez M, Fox E. Effects of Fansidar on chloroquine-resistant Plasmodium falciparum in Pakistan. Am J Trop Med Hyg. 1986;35:61-5.
81. Hii JL, Vun YS, Chin KF, Chua R, Tambakau S, Binisol ES, et al. The influence of permethrin-impregnated bednets and mass drug administration on the incidence of Plasmodium falciparum malaria in children in Sabah, Malaysia. Med Vet Entomol. 1987;1:397-407.
82. Babione RW. Epidemiology of malaria eradication. II. Epidemiology of malaria eradication in Central America: a study of technical problems. Am J Public Health Nations Health. 1966;56:76-90.
83. Chaudhuri RN, Janardan Poti S. Suppressive treatment of malaria; with statistical analysis. Indian J Malariol. 1950;4:115-33.
84. Edeson JF, Wharton RH, Wilson T, Reid JA. An experiment in the control of rural malaria in Malaya. Med J Malaya. 1957;12:319-47.
85. Omer AH. Species prevalence of malaria in northern and southern Sudan, and control by mass chemoprophylaxis. Am J Trop Med Hyg. 1978;27:858-63.